Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Bevyxxa (betrixaban) for the Treatment of Venous Thromboembolism (VTE) in Adults

Drug (Brand/Generic)

Bevyxxa (betrixaban)

Company/Licensee

Portola Pharmaceuticals

Therapy Class

Anti-thrombotic

Current Indication

Venous thromboembolism (VTE)

Market Sector

Cardiovascular

Development Status

Approved in the US
Expand

Go Top